COG3
protein-codingcomponent of oligomeric golgi complex 3, the group of Components of oligomeric golgi complex
Gene summary
This gene encodes a component of the conserved oligomeric Golgi (COG) complex which is composed of eight different subunits and is required for normal Golgi morphology and localization. Defects in the COG complex result in multiple deficiencies in protein glycosylation. The protein encoded by this gene is involved in ER-Golgi transport.[provided by RefSeq, Jun 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~71.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0015286
Submitter: ClinGen
*COG3* was first reported in relation to an autosomal recessive congenital disorder of glycosylation in 2023 (Duan et al., PMID: 37711075). Two families have been reported with biallelic variants in the gene. These individuals presented with global developmental delay and severe intellectual disability, microcephaly, epilepsy, facial dysmorphism, and variable neurological findings. Serum transferrin studies, carried out for affected individuals in one of the families showed reduced sialylation. Congenital Disorder of Glycosylation (specifically Congenital disorder of glycosylation, type IIbb, MIM# 606975; also known as COG3-CDG) is the only monogenic disorder asserted to be caused by variants in *COG3*. Two different missense variants have been reported, each in one of the two reported families (Duan et al, 2023, PMID: 37711075). The mechanism of disease is unknown but assumed to be loss of function. (Total points for genetic evidence = 1.5 points) This gene-disease relationship is also supported by experimental evidence including the biochemical function of COG3, a subunit of the COG complex, which is important in intra Golgi and Golgi to ER retrograde transport (Zolov and Lupashin, 2005, PMID: 15728195; Shestakova et al, 2006, PMID: 16420527), protein interaction studies showing physical interaction of COG3 with other COG subunits that have been implicated in CDG (Lees et al, 2010, PMID: 20972446; Ishii et al, 2018, PMID: 29899178), and functional alteration studies in patient and non-patient cells showing defects in retrograde transport (Duan et al, 2023, PMID: 37711075; Pokrovskaya et al, 2011, PMID: 21421995). (Total points for experimental evidence = 5 points). In summary, there is limited evidence supporting the relationship between *COG3* and an autosomal recessive congenital disorder of glycosylation. This classification was approved by the ClinGen Congenital Disorders of Glycosylation Gene Curation Expert Panel on September 18, 2024 (SOP Version #11)
Inheritance Pattern: AR
Disease ID:MONDO:0957820
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COG3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_031431.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 95 | 2 | 97 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 101 | 2 | 0 | 103 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_113619.3 | 23 | MANE Select | |
| Ensembl | ENSP00000258654.8 | 23 | MANE Select | |
| Ensembl | ENSP00000482221.1 | 2 | Standard | |
| Ensembl | ENSP00000477882.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Post-translational protein modification
- Metabolism of proteins
- Transport to the Golgi and subsequent modification
Biological Process
- protein glycosylation
- intracellular protein transport
- endoplasmic reticulum to Golgi vesicle-mediated transport
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
- intra-Golgi vesicle-mediated transport
Molecular Function
- protein binding
- protein transporter activity
Cellular Component
- Golgi membrane
- Golgi apparatus
- cis-Golgi network
- cytosol
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000349995
- Coding exons
- 23
- Length
- 71706
- Individuals with no LoFs
- 125725
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 23
- Defined
- 125748
- p
- 0.0000915
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.57 | 331 | 422 | 0.785 | 0.0000204 | 5404 |
| Missense (PolyPhen) | 86 | 130.19 | 0.66059 | 1670 | ||
| Synonymous | 0.949 | 151 | 167 | 0.906 | 0.00000867 | 1537 |
| Loss of Function | 5.84 | 5 | 49.2 | 0.102 | 0.00000230 | 628 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000088 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00032 | 0.00032 | rare |
| European (Non-Finnish) | 0.000054 | 0.000053 | rare |
| South Asian | 0.00029 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in ER-Golgi transport. {ECO:0000269|PubMed:11929878}.;
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 34.82
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.916
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |